Vasopressin pressor receptor-mediated activation of HPA axis by acute ethanol stress in rats

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 280, Issue 2 49-2, 2001, Pages

  László, Ferenc A ^a   Varga, Csaba ^a   Pávó, Imre ^b   Gardi, János ^b   Vecsernyés, Miklós ^b   Gálfi, Márta ^b   Morschl, Éva ^c   László, Ferenc ^c   Makara, Gábor B ^c  

^a UNIVERSITY OF SZEGED   (Hungary)

^b UNIVERSITY OF SZEGED   (Hungary)

^c INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

Adrenocorticotropic hormone; Corticosterone; Hypothalamic corticotropin releasing hormone; V1 receptor antagonist

Indexed keywords

ALCOHOL; VASOPRESSIN; VASOPRESSIN RECEPTOR ANTAGONIST;

ADRENALECTOMY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; HORMONE RELEASE; HORMONE RESPONSE; HYPOTHALAMUS HYPOPHYSIS SYSTEM; IMMOBILIZATION STRESS; MEDIATOR RELEASE; NONHUMAN; PRESSOR RESPONSE; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; STIMULUS RESPONSE; STOMACH EROSION; STOMACH MUCOSA;

EID: 0343773091     PISSN: 03636119     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpregu.2001.280.2.r458     Document Type: Article

References (70)

1. Aguilera G. Corticotropin releasing hormone, receptor regulation and the stress response. Trends Endocrinol Metab 9: 329-336, 1998.
2. Aizawa T, Yasuda N, Greer MA, and Sawyer WH. In vivo adrenocorticotropin-releasing activity of neurohypophyseal hormones and their analogs. Endocrinology 110: 98-104, 1982.
3. Anderson SM, Kant GJ, and De-Souza EB. Effects of chronic stress on anterior pituitary and brain corticotropin-releasing factor receptors. Pharmacol Biochem Behav 44: 755-761, 1993.
4. Antoni FA, Holmes MC, Makara GB, Kárteszi M, and László FA. Evidence that the effects of arginine-8-vasopressin (AVP) on pituitary corticotropin (ACTH) release are mediated by a novel type of receptor. Peptides 5: 519-522, 1984.
5. Arimura A, Saito T, Bowers CY, and Schally AV. Pituitary-adrenal activation in rats with hereditary hypothalamic diabetes insipidus. Acta Endocrinol 54: 155-165, 1967.
6. Baertschi AJ and Friedli M. A novel type of vasopressin receptor on anterior pituitary corticotrophs? Endocrinology 116: 499-502, 1985.
7. Ben-Manachem T, Fogel R, Patel RV, Touchette M, Zarowitz BJ, Hadzijahic N, Divine G, Verter J, and Bresalier RS. Prophylaxis for stress-related gastric hemorrhage in the intensive care unit. Ann Intern Med 121: 568-574, 1994.
8. Bernardini R, Chiarenza A, Kamilaris TC, Renaud N, Lempereur L, Demitrack M, Gold PW, and Chrousos GP. In vivo and in vitro effects of arginine-vasopressin receptor antagonists on the hypothalamic-pituitary-adrenal axis in the rat. Neuroendocrinology 60: 503-508, 1994.
9. Buckingham JC. Vasopressin receptors influencing the secretion of ACTH by the rat adenohypophysis. J Endocrinol 113: 389-396, 1987.
10. Chappell PB, Smith MA, Kilts CD, Bissette G, Ritchie J, Anderson C, and Nemeroff CB. Alerations in corticotropin-releasing factor-like immunoreactivity in discrete rat brain regions after acute and chronic stress. J Neurosci 6: 2908-2914, 1986.
11. Conte-Devolx B, Oliver C, Giraud P, Castanas E, Boudouresque F, Gillioz P, and Millet Y. Adrenocorticotropin and corticosterone secretion in Brattleboro rats. Endocrinology 110: 2097-2100, 1982.
12. Dupouy JP and Chatelain A. In vitro effects of corticosterone, synthetic ovine corticotrophin releasing factor and arginine vasopressin on the release of adrenocorticotrophin by fetal rat pituitary glands. J Endocrinol 101: 339-344, 1984.
13. Guillaume V, Conte-Devolx B, Magnan E, Boudouresque F, Grino M, Cataldi M, Muret L, Priou A, Figaroli JC, and Oliver C. Effect of chronic active immunization with antiarginine vasopressin on pituitary-adrenal function in sheep. Endocrinology 130: 3007-3014, 1992.
14. Haas DA and George SR. Single or repeated mild stress increases synthesis and release of hypothalamic corticotropin-releasing factor. Brain Res 461: 230-237, 1988.
15. Harbuz MS and Lightman SL. Glucocorticoid inhibition of stress-induced changes in hypothalamic corticotropin-releasing factor messenger RNA and proenkephalin A messenger RNA. Neuropeptides 14: 17-20, 1989.
16. Harbuz MS and Lightman SL. Responses of hypothalamic and pituitary mRNA to physical and physiological stress in the rat. J Endocrinol 122: 705-711, 1989.
17. Janáky T, Tóth G, Penke B, Kovács K, and László FA. Iodination of peptide hormones and purification of iodinated peptides. J Liq Chromatogr 5: 1499-1507, 1982.
18. Jard S, Gaillard RC, Guillon G, Marie J, Schoenenberg P, Muller AF, Manning M, and Sawyer WH. Vasopressin antagonists allow demonstration of a novel type of vasopressin receptor in the rat adenohypophysis. Mol Pharmacol 30: 171-177, 1986.
19. Julesz J, Gálfi M, Molnár J, and Vecsernyés M. Central effects of tricyclic compounds on the endocrine system - an in vitro study. Prog Brain Res 91: 89-92, 1992.
20. Kalin NH, Takahashi LK, and Chen FL. Restraint stress increases corticotropin-releasing hormone mRNA content in the amygdala and paraventricular nucleus. Brain Res 656: 182-186, 1994.
21. Kjaer A. Vasopressin as a neuroendocrine regulator of anterior pituitary hormone secretion. Acta Endocrinol 129: 489-496, 1993.
22. Kjaer A, Knigge U, Bach FW, and Warberg J. Impaired histamine- and stress-induced secretion of ACTH and beta-endorphin in vasopressin-deficient Brattleboro rats. Neuroendocrinology 57: 1035-1041, 1993.
23. Knepel W, Götz D, and Fahrenholz F. Interaction of rat adenohypophyseal vasopressin receptors with vasopressin analogues substituted at position 7 and 1: dissimilarity from the V1 vasopressin receptor. Neuroendocrinology 44: 390-396, 1986.
24. Kovács KJ and Makara GB. Corticosterone and dexamethasone act at different brain sites to inhibit adrenalectomy-induced adreno-corticotropin hypersection. Brain Res 474: 205-210, 1988.
25. Laczi F, Iványi T, Julesz J, Janáky T, and László FA. Plasma 8-arginine-vasopressin responses to osmotic or histamine stimulation contribute to the differential diagnosis of central diabetes insipidus. Acta Endocrinol 113: 168-174, 1986.
26. Lamberts SWJ, Verleun T, Oosterom R, Dejong F, and Hackeng WHL. Corticotropin-releasing factor (ovine) and vasopressin exert a synergistic effect on adrenocorticotropin release in man. J Clin Endocrinol Metab 58: 298-303, 1984.
27. László F, Amani E, Karácsony G, Szabó E, Rengei B, Varga C, and László FA. The modulatory role of endogenous vasopressin in the phenomenon that orally administered ethanol generates more severe gastric erosions in male than in female rats. Ann NY Acad Sci 689: 623-626, 1993.
28. László F, Karácsony G, Pávó I, Varga C, Rojik I, and László FA. Aggressive role of vasopressin in development of different gastric lesions in rats. Eur J Pharmacol 258: 15-22, 1994.
29. László F, Karácsony G, Szabó E, Láng J, Baláspiri L, and László FA. The role of vasopressin in the pathogenesis of ethanol-induced gastric hemorrhagic erosions in rats: is vasopressin an endogenous aggressor toward the gastric mucosa? Gastroenterology 101: 1242-1248, 1991.
30. László FA, László F Jr, and De Wied D. Pharmacology and clinical perspectives of vasoopressin antagonists. Pharmacol Rev 43: 73-108, 1991.
31. László F, Pávó I, Szepes Z, Varga C, and László FA. Deleterious action of vasopressin in gastroduodenal ulceration: experimental and clinical observations. Scand J Gastroenterol 33, Suppl 228: 62-67, 1998.
32. Lightman SL and Young WS. Corticotropin-releasing factor, vasopressin and pro-opiomelanocortin mRNA responses to stress and opiates in the rat. J Physlol 403: 511-523, 1988.
33. Linkola J, Ylikahri R, Fyhrquist F, and Wallenius M. Plasma vasopressin in ethanol intoxication and hangover. Acta Physiol Scand 104: 180-187, 1978.
34. Linton EA and Lowry PJ. Radioimmunoassay and chromatographic characterization of CRF-41-like immunoreactivity in hypothalami from several species. Neuropeptides 3: 45-52, 1982.
35. Linton EA, Tilders FJH, Hodgkinson S, Berkenbosch F, Vermes I, and Lowry PJ. Stress-induced secretion of adrenocorticotropin in rats is inhibited by administration of antisera to ovine corticotropin-releasing factor and vasopressin. Endocrinology 116: 966-970, 1985.
36. Liu JH, Muse K, Contreras P, Gibbs D, Vale W, Rivier J, and Yen SSC. Augmentation of ACTH-releasing activity of synthetic corticotropin releasing factor (CRF) by vasopressin in women. J Clin Endocrinol Metab 57: 1087-1089, 1983.
37. Lowry OH, Rosenbrough NJ, Farr AL, and Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem 193: 265-275, 1951.
38. Luo X, Kiss A, Makara G, Lolait SJ, and Aguilera G. Stress-specific regulation of corticotropin releasing hormone receptor expression in the paraventricular and supraoptic nuclei of the hypothalamus in the rat. J Neuroendocrinol 6: 689-696, 1994.
39. MacIsaac RJ, Congiu M, Levidiotis M, McDougall JG, and Wintour EM. In vivo regulation of adrenocorticotrophin secretion in the immature ovine fetus. Modulation by ovine corticotrophin releasing hormone and arginine vasopressin. J Dev Physiol 12: 41-47, 1989.
40. Manning M and Sawyer WH. Synthesis and receptor specificities of vasopressin antagonists. J Cardiovasc Pharmacol 8, Suppl 7: S29-S35, 1989.
41. Manning M and Sawyer WH. Discovery, development, and some uses of vasopressin and oxytocin antagonists. J Lab Clin Med 114: 617-632, 1989.
42. Maser-Gluth C and Vecsei P. Corticotropin-releasing factor-like immunoreactivity in human 24 h urine. Clin Endocrinol (Oxf) 30: 405-412, 1989.
43. McCann SM, Antunes-Rodrigues J, Nallar R, and Valtin H. Pituitary-adrenal function in the absence of vasopressin. Endocrinology 79: 1058-1064, 1966.
44. Mihály K, Makara GB, and Stark E. Radioimmunoassay for corticosterone. In: Proceeding of the Symposium on the Analysis of Steroids, edited by Görög S. Budapest, Hungary: Academic, 1981, p. 217-221.
45. Moldow RL, Kastin AJ, Graf M, and Fischman AJ. Stress mediated changes in hypothalamic corticotropin-releasing factor-like immunoreactivity. Life Sci 40: 413-418, 1987.
46. Mormede P, LeMoal M, and Dantzer R. Analysis of the dual mechanism of ACTH release by arginine vasopressin and its analogs in conscious rats. Regul Pept 12: 175-184, 1985.
47. Murakami K, Akana S, Dallman MF, and Ganong WF. Correlation between the stress-induced transient increase in corticotropin-releasing hormone content of the median eminence of the hypothalamus and adrenocorticotrophic hormone secretion. Neuroendocrinology 49: 233-241, 1989.
48. Nishioka T, Iyota K, Nakayama T, Suemaru S, Numata Y, and Hashimoto K. Effects of ether laparatomy and water immersion-restraint stress on CRH concentration in the hypothalamus, extrahypothalamic tissues and peripheral blood. Endocr J 40: 213-220, 1993.
49. Ono N, de Castro JB, Khorram O, and McCann SM. Role of arginine vasopressin in control of ACTH and LH release during stress. Life Sci 36: 1779-1786, 1985.
50. Owens MJ and Nemeroff CB. Physiology and pharmacology of corticotropin-releasing factor. Pharmacol Rev 43: 425-473, 1991.
51. Plotsky PM and Meaney MJ. Early, postnatal experience alters hypothalamic corticotropin-releasing factor (CRF) mRNA, median eminence CRF content and stress-induced release in adult rats. Mol Brain Res 18: 195-200, 1993.
52. Rabadan-Diehl C, Kiss A, Camacho C, and Aguilera G. Regulation of messenger ribonucleic acid for corticotropin releasing hormone receptor in the pituitary during stress. Endocrinology 137: 3808-3814, 1996.
53. Reichlin S. Neuroendocrinology. In: Textbook of Endocrinology (7th ed.), edited by Williams RH. Philadelphia, PA: Saunders, 1985, p. 492-567.
54. Rivest S and Rivier C. Lesions of hypothalamic PVN partially attenuate stimulatory action of alcohol on ACTH secretion in rats. Am J Physiol Regulatory Integrative Comp Physiol 266: R553-R558, 1994.
55. Rivier C, Bruhn T, and Vale W. Effect of ethanol on the hypothalamic-pituitary-adrenal axis in the rat: role of corticotropin-releasing factor (CRF). J Pharmacol Exp Ther 229: 127-131, 1984.
56. Rivier C and Lee S. Acute alcohol administration stimulates the activity of hypothalamic neurons that express corticotropin-releasing factor and vasopressin. Brain Res 726: 1-10, 1996.
57. Rivier C, Rivier J, Mormede P, and Vale W. Studies of the nature of the interaction between vasopressin and corticotropin-releasing factor on adrenocorticotropin release in the rat. Endocrinology 115: 882-886, 1984.
58. Rivier C and Vale W. Neuroendocrine interaction between corticotropin releasing factor and vasopressin on adrenocorticotropic hormone secretion in the rat. In: Vasopressin, edited by Schrier RW. New York: Raven, 1985, p. 181-188.
59. Rivier C and Vale W. Modulation of stress-induced ACTH release by corticotropin-releasing factor, cathecolamines and vasopressin. Nature 305: 325-327, 1983.
60. Robert A. Cytoprotection by prostaglandins. Gastroenterology 77: 761-767, 1979.
61. Robert A and Kauffman GL. Stress ulcers, erosions, and gastric mucosal injury. In: Gastrointestinal Disease, Pathophysiology, Diagnosis, Management, edited by Sleisenger MH and Fordtran JS. Philadelphia, PA: Saunders, 1989, p. 772-795.
62. Robertson GL. Posterior pituitary. In: Endocrinology and Metabolism (2nd ed.), edited by Felig P, Baxter JW, Broadus AE, and Frohman LA. New York: McGraw-Hill, 1987, p. 335-341.
63. Sarnyai Z, Bíró É, Gardi J, Vecsernyés M, Julesz J, and Telegdy GY. Alterations of corticotropin-releasing factor-like immunoreactivity in different brain regions after acute cocaine administration in rats. Brain Res 616: 315-319, 1993.
64. Schwartz J and Reid IA. Characteristics of the receptors which mediate the stimulation of ACTH secretion by vasopressin in conscious dogs. Neuroendocrinology 42: 93-96, 1986.
65. Szabó S, Gallagher GT, Horner HC, Frankel PW, Underwood RH, Konturek SJ, Brzozowski J, and Trier JS. Role of adrenal cortex in gastric mucosal protection by prostaglandins, sulfhydryls, and cimetidine in the rat. Gastroenterology 85: 1384-1390, 1983.
66. Vale W, Vaughan J, Smith M, Yamamoto G, Rivier J, and Rivier C. Effects of synthetic ovine corticotropin-releasing factor, glucocorticoids, catecholamines, neurohypophysial peptides, and other substances on cultured corticotropic cells. Endocrinology 113: 1121-1131, 1983.
67. Varga C, Pávó I, Lamarque D, Szepes Z, Kiss J, Karácsony G, László FA, and László F. Endogenous vasopressin increases acute endotoxin shock-provoked gastrointestinal mucosal injury in the rat. Eur J Pharmacol 352: 257-261, 1998.
68. Watabe T, Tanaka K, Kumagae M, Itoh S, Kogure M, Hasegawa M, Horiuchi T, Morio K, Takeda F, and Ubukata E. Role of endogenous arginine vasopressin in potentiating corticotropin-releasing hormone-stimulated corticotropin secretion in man. J Clin Endocrinol Metab 66: 1132-1137, 1988.
69. Wiley MK, Pearlmutter AF, and Miller RE. Decreased adrenal sensitivity to ACTH in the vasopressin-deficient (Brattleboro) rat. Neuroendocrinology 14: 257-270, 1974.
70. Yates FE, Russel SM, Dallman MF, Hodge GA, MacCann SM, and Dhariwal AP. Potentiation by vasopressin of corticotropin release induced by corticotropin-releasing factor. Endocrinology 88: 3-15, 1971.